Company Announcements

Commercial Development Agreement with Valkor

Source: RNS
RNS Number : 9285H
Quadrise Fuels International PLC
11 April 2022
 

11 April 2022

 

Quadrise Fuels International plc

("Quadrise," "QFI" or the "Company")

 

Commercial Development Agreement with Valkor Technologies LLC

 

Quadrise is pleased to announce the execution of a phased Commercial Development Agreement ("CDA") with Valkor Technologies LLC ("Valkor") headquartered in Park City, Utah, to commercialise Quadrise's MSAR® and bioMSAR technology at Valkor's projects in Utah state in the USA.

 

Under Phase 1 of the CDA, to be completed by 30 June 2022:

 

·    Valkor will deliver a crude oil sample from a heavy oil asset in Utah in which they have an existing equity interest (the 'Primary Project') to Quadrise.

·    Quadrise will perform analysis and testing on the sample to confirm that it is suitable to produce MSAR® and bioMSAR.

·    Quadrise and Valkor will together and in the same time frame:

Negotiate supply agreements with identified target consumers of MSAR® and bioMSAR™ fuel to be produced by the Primary Project.

Finalise the technical and operational requirements and commercial terms for license and supply of QFI technology.


Full commercial terms for an MSAR
® and/or bioMSAR License and Supply Agreement at the Primary Project would then be concluded no later than October 2022.

 

Under Phase 2 of the CDA, following the conclusion of a License and Supply Agreement covering the Primary Project, Quadrise intends to grant Valkor exclusive terms over the deployment of QFI technology in the State of Utah. This is expected to take the form of further Licence and Supply Agreement(s) or Tolling Agreement(s) for projects on which QFI technology is proposed to be deployed.

 

Net profits generated under the License and Supply Agreement(s) or Tolling Agreement(s) are to be shared between Quadrise and Valkor, based on the respective contribution by each party to the deployment of QFI technology for each project.

Jason Miles, CEO of Quadrise Fuels International, commented:

"The need for more economical and lower carbon industrial and marine fuels has never been more apparent. Quadrise is delighted to have executed this agreement and looks forward to working expeditiously with the Valkor team to conclude commercial agreements for supply of MSAR® and bioMSAR for identified projects."

Steven Byle, CEO of Valkor, added:

"We are delighted to work jointly with Quadrise to secure high value opportunities for our Utah heavy sweet oil projects, following the successful testing completed on oil sands samples from the pilot plant last year. The supply and licensing of MSAR® technology in Utah is conditional on securing the first opportunity for fuel supply and offtake, and we look forward to working closely with Quadrise during the coming months on this commercial opportunity."

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc


Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

+44 (0)20 7031 7321



Nominated Adviser


Cenkos Securities plc


Ben Jeynes

+44 (0)20 7397 8900

Katy Birkin


 

Broker

Shore Capital Stockbrokers Limited


Toby Gibbs

+44 (0)20 7408 4090

Fiona Conroy


Public & Investor Relations


Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230



Notes to Editors

 


Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels in the global power generation, shipping, industrial and refining industries.

 

This announcement is inside information for the purposes of article 7 of Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFIFEESTILLIF